These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33645387)

  • 1. Pharmacoeconomics of allergy immunotherapy versus pharmacotherapy.
    Cox L
    Expert Rev Clin Immunol; 2021 Mar; 17(3):255-268. PubMed ID: 33645387
    [No Abstract]   [Full Text] [Related]  

  • 2. The Cost-Effectiveness of Allergen Immunotherapy Compared with Pharmacotherapy for Treatment of Allergic Rhinitis and Asthma.
    Cox LS; Murphey A; Hankin C
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):69-85. PubMed ID: 31761122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergy immunotherapy in reducing healthcare cost.
    Cox L
    Curr Opin Otolaryngol Head Neck Surg; 2015 Jun; 23(3):247-54. PubMed ID: 25887973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview.
    Asaria M; Dhami S; van Ree R; Gerth van Wijk R; Muraro A; Roberts G; Sheikh A
    Allergy; 2018 Feb; 73(2):269-283. PubMed ID: 28718981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of allergen immunotherapy in the management of allergic rhinitis.
    Cox L
    Am J Rhinol Allergy; 2016; 30(1):48-53. PubMed ID: 26867530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does evidence support the use of cat allergen immunotherapy?
    Dhami S; Agarwal A
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in allergic rhinitis and lower airway outcomes.
    Cardona V; Luengo O; Labrador-Horrillo M
    Allergy; 2017 Jan; 72(1):35-42. PubMed ID: 27439141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to Patients with Allergic Rhinitis: Testing and Treatment.
    Cox L
    Med Clin North Am; 2020 Jan; 104(1):77-94. PubMed ID: 31757239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma.
    Brunton S; Nelson HS; Bernstein DI; Lawton S; Lu S; Nolte H
    Postgrad Med; 2017 Aug; 129(6):581-589. PubMed ID: 28326908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare costs associated with allergic rhinitis, asthma allergy immunotherapy.
    Tesch F; Sydendal Grand T; Wuestenberg E; Elliott L; Schmitt J; Kuster D
    Eur Ann Allergy Clin Immunol; 2020 Jul; 52(4):164-174. PubMed ID: 31818082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting.
    Björstad Å; Cardell LO; Hahn-Pedersen J; Svärd M
    Clin Drug Investig; 2017 Jun; 37(6):541-549. PubMed ID: 28326466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.
    Passalacqua G; Canonica GW; Bagnasco D
    Curr Allergy Asthma Rep; 2016 Nov; 16(12):88. PubMed ID: 27957697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What you should not miss from the systematic reviews and meta-analyses on allergen-specific immunotherapy in 2017.
    Larenas-Linnemann D; Luna-Pech JA
    Curr Opin Allergy Clin Immunol; 2018 Jun; 18(3):168-176. PubMed ID: 29629956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. House dust mites-driven allergic rhinitis: could its natural history be modified?
    Ciprandi G; Tosca MA
    Expert Rev Clin Immunol; 2021 Feb; 17(2):109-114. PubMed ID: 33472013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responders and nonresponders to pharmacotherapy and allergen immunotherapy.
    Jakalski M; Bozek A; Canonica GW
    Hum Vaccin Immunother; 2019; 15(12):2896-2902. PubMed ID: 31070995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International consensus on allergy immunotherapy.
    Jutel M; Agache I; Bonini S; Burks AW; Calderon M; Canonica W; Cox L; Demoly P; Frew AJ; O'Hehir R; Kleine-Tebbe J; Muraro A; Lack G; Larenas D; Levin M; Nelson H; Pawankar R; Pfaar O; van Ree R; Sampson H; Santos AF; Du Toit G; Werfel T; Gerth van Wijk R; Zhang L; Akdis CA
    J Allergy Clin Immunol; 2015 Sep; 136(3):556-68. PubMed ID: 26162571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SQ house dust mite sublingual immunotherapy for the treatment of adults with house dust mite-induced allergic rhinitis.
    Meteran H; Backer V
    Expert Rev Clin Immunol; 2019 Nov; 15(11):1127-1133. PubMed ID: 31584839
    [No Abstract]   [Full Text] [Related]  

  • 19. 2019 ARIA Care pathways for allergen immunotherapy.
    Bousquet J; Pfaar O; Togias A; Schünemann HJ; Ansotegui I; Papadopoulos NG; Tsiligianni I; Agache I; Anto JM; Bachert C; Bedbrook A; Bergmann KC; Bosnic-Anticevich S; Bosse I; Brozek J; Calderon MA; Canonica GW; Caraballo L; Cardona V; Casale T; Cecchi L; Chu D; Costa E; Cruz AA; Czarlewski W; Durham SR; Du Toit G; Dykewicz M; Ebisawa M; Fauquert JL; Fernandez-Rivas M; Fokkens WJ; Fonseca J; Fontaine JF; Gerth van Wijk R; Haahtela T; Halken S; Hellings PW; Ierodiakonou D; Iinuma T; Ivancevich JC; Jacobsen L; Jutel M; Kaidashev I; Khaitov M; Kalayci O; Kleine Tebbe J; Klimek L; Kowalski ML; Kuna P; Kvedariene V; La Grutta S; Larenas-Linemann D; Lau S; Laune D; Le L; Lodrup Carlsen K; Lourenço O; Malling HJ; Marien G; Menditto E; Mercier G; Mullol J; Muraro A; O'Hehir R; Okamoto Y; Pajno GB; Park HS; Panzner P; Passalacqua G; Pham-Thi N; Roberts G; Pawankar R; Rolland C; Rosario N; Ryan D; Samolinski B; Sanchez-Borges M; Scadding G; Shamji MH; Sheikh A; Sturm GJ; Todo Bom A; Toppila-Salmi S; Valentin-Rostan M; Valiulis A; Valovirta E; Ventura MT; Wahn U; Walker S; Wallace D; Waserman S; Yorgancioglu A; Zuberbier T;
    Allergy; 2019 Nov; 74(11):2087-2102. PubMed ID: 30955224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives in allergen immunotherapy: 2019 and beyond.
    Pfaar O; Agache I; de Blay F; Bonini S; Chaker AM; Durham SR; Gawlik R; Hellings PW; Jutel M; Kleine-Tebbe J; Klimek L; Kopp MV; Nandy A; Rabin RL; van Ree R; Renz H; Roberts G; Salapatek AM; Schmidt-Weber CB; Shamji MH; Sturm GJ; Virchow JC; Wahn U; Willers C; Zieglmayer P; Akdis CA
    Allergy; 2019 Dec; 74 Suppl 108():3-25. PubMed ID: 31872476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.